APO RESEARCH · REPORT
25G Transconjunctival Sutureless Vitrectomy System
25G Transconjunctival Sutureless Vitrectomy System is a medical imaging or procedural device supplied for the named examination or intervention.

Product & engineering
Understand the product.
The imaging or procedural modality, patient interface, connected instruments and product-specific validation define its use. Device appearance or a dimensional label does not establish an indication or clinical outcome.
The commercial boundary
The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.
Which modality and connected clinical interfaces define the device?
The imaging or procedural modality, patient interface, connected instruments and product-specific validation define its use. Device appearance or a dimensional label does not establish an indication or clinical outcome.
Selected research
Market Structure
Global 25G Transconjunctival Sutureless Vitrectomy System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 25G Transconjunctival Sutureless Vitrectomy System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 25G Transconjunctival Sutureless Vitrectomy System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 25G Transconjunctival Sutureless Vitrectomy System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 25G Transconjunctival Sutureless Vitrectomy System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 25G Transconjunctival Sutureless Vitrectomy System include Alcon, Bausch + Lomb, Dutch Ophthalmic Research Center, NIDEK, Beijing Kangruide Medical Technology, Shanghai Fosun Pharmaceutical Group, Shanghai New Vision Ophthalmic Equipment, Shenzhen Ophthalmic Equipment and Suzhou Synergy Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global 25G Transconjunctival Sutureless Vitrectomy System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 25G Transconjunctival Sutureless Vitrectomy System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 25G Transconjunctival Sutureless Vitrectomy System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 25G Transconjunctival Sutureless Vitrectomy System market size, projected growth trends, production technologies, key applications, and end-use industries.
25G Transconjunctival Sutureless Vitrectomy System Segment by Company
Alcon
Bausch + Lomb
Dutch Ophthalmic Research Center
NIDEK
Beijing Kangruide Medical Technology
Shanghai Fosun Pharmaceutical Group
Shanghai New Vision Ophthalmic Equipment
Shenzhen Ophthalmic Equipment
Suzhou Synergy Medical Technology
25G Transconjunctival Sutureless Vitrectomy System Segment by Type
Standard
Combination
25G Transconjunctival Sutureless Vitrectomy System Segment by Application
Ophthalmology
Other
25G Transconjunctival Sutureless Vitrectomy System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 25G Transconjunctival Sutureless Vitrectomy System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 25G Transconjunctival Sutureless Vitrectomy System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 25G Transconjunctival Sutureless Vitrectomy System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 25G Transconjunctival Sutureless Vitrectomy System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 25G Transconjunctival Sutureless Vitrectomy System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 25G Transconjunctival Sutureless Vitrectomy System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of 25G Transconjunctival Sutureless Vitrectomy System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Standard
- Combination
Applications
- Ophthalmology
- Other
Companies covered
- Alcon
- Bausch + Lomb
- Dutch Ophthalmic Research Center
- NIDEK
- Beijing Kangruide Medical Technology
- Shanghai Fosun Pharmaceutical Group
- Shanghai New Vision Ophthalmic Equipment
- Shenzhen Ophthalmic Equipment
- Suzhou Synergy Medical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Estimates and Forecasts (2021-2032)
- 1.5 Global 25G Transconjunctival Sutureless Vitrectomy System Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global 25G Transconjunctival Sutureless Vitrectomy System Market Dynamics
- 2.1 25G Transconjunctival Sutureless Vitrectomy System Industry Trends
- 2.2 25G Transconjunctival Sutureless Vitrectomy System Industry Drivers
- 2.3 25G Transconjunctival Sutureless Vitrectomy System Industry Opportunities and Challenges
- 2.4 25G Transconjunctival Sutureless Vitrectomy System Industry Restraints
3 25G Transconjunctival Sutureless Vitrectomy System Market by Manufacturers
- 3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Manufacturers (2021-2026)
- 3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Manufacturers (2021-2026)
- 3.3 Global 25G Transconjunctival Sutureless Vitrectomy System Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global 25G Transconjunctival Sutureless Vitrectomy System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 25G Transconjunctival Sutureless Vitrectomy System Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 25G Transconjunctival Sutureless Vitrectomy System Manufacturers, Product Type & Application
- 3.7 Global 25G Transconjunctival Sutureless Vitrectomy System Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 25G Transconjunctival Sutureless Vitrectomy System Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 25G Transconjunctival Sutureless Vitrectomy System Players Market Share by Revenue in 2025
- 3.8.3 2025 25G Transconjunctival Sutureless Vitrectomy System Tier 1, Tier 2, and Tier 3
4 25G Transconjunctival Sutureless Vitrectomy System Market by Type
- 4.1 25G Transconjunctival Sutureless Vitrectomy System Type Introduction
- 4.1.1 Standard
- 4.1.2 Combination
- 4.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Type
- 4.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Type (2021-2032)
- 4.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Share by Type (2021-2032)
- 4.3 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type
- 4.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type (2021-2032)
- 4.3.3 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Market Share by Type (2021-2032)
5 25G Transconjunctival Sutureless Vitrectomy System Market by Application
- 5.1 25G Transconjunctival Sutureless Vitrectomy System Application Introduction
- 5.1.1 Ophthalmology
- 5.1.2 Other
- 5.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application
- 5.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application (2021-2032)
- 5.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Share by Application (2021-2032)
- 5.3 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application
- 5.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application (2021-2032)
- 5.3.3 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Market Share by Application (2021-2032)
6 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region
- 6.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region (2021-2032)
- 6.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region (2021-2026)
- 6.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 25G Transconjunctival Sutureless Vitrectomy System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 25G Transconjunctival Sutureless Vitrectomy System Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region
- 7.1 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region
- 7.1.1 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region (2021-2026)
- 7.1.3 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region (2027-2032)
- 7.1.4 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America 25G Transconjunctival Sutureless Vitrectomy System Revenue (2021-2032)
- 7.2.2 North America 25G Transconjunctival Sutureless Vitrectomy System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe 25G Transconjunctival Sutureless Vitrectomy System Revenue (2021-2032)
- 7.3.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Revenue (2021-2032)
- 7.4.2 Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Alcon
- 8.1.1 Alcon Company Information
- 8.1.2 Alcon Business Overview
- 8.1.3 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Alcon 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.1.5 Alcon Recent Developments
- 8.2 Bausch + Lomb
- 8.2.1 Bausch + Lomb Company Information
- 8.2.2 Bausch + Lomb Business Overview
- 8.2.3 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.2.5 Bausch + Lomb Recent Developments
- 8.3 Dutch Ophthalmic Research Center
- 8.3.1 Dutch Ophthalmic Research Center Company Information
- 8.3.2 Dutch Ophthalmic Research Center Business Overview
- 8.3.3 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.3.5 Dutch Ophthalmic Research Center Recent Developments
- 8.4 NIDEK
- 8.4.1 NIDEK Company Information
- 8.4.2 NIDEK Business Overview
- 8.4.3 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.4.5 NIDEK Recent Developments
- 8.5 Beijing Kangruide Medical Technology
- 8.5.1 Beijing Kangruide Medical Technology Company Information
- 8.5.2 Beijing Kangruide Medical Technology Business Overview
- 8.5.3 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.5.5 Beijing Kangruide Medical Technology Recent Developments
- 8.6 Shanghai Fosun Pharmaceutical Group
- 8.6.1 Shanghai Fosun Pharmaceutical Group Company Information
- 8.6.2 Shanghai Fosun Pharmaceutical Group Business Overview
- 8.6.3 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.6.5 Shanghai Fosun Pharmaceutical Group Recent Developments
- 8.7 Shanghai New Vision Ophthalmic Equipment
- 8.7.1 Shanghai New Vision Ophthalmic Equipment Company Information
- 8.7.2 Shanghai New Vision Ophthalmic Equipment Business Overview
- 8.7.3 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.7.5 Shanghai New Vision Ophthalmic Equipment Recent Developments
- 8.8 Shenzhen Ophthalmic Equipment
- 8.8.1 Shenzhen Ophthalmic Equipment Company Information
- 8.8.2 Shenzhen Ophthalmic Equipment Business Overview
- 8.8.3 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.8.5 Shenzhen Ophthalmic Equipment Recent Developments
- 8.9 Suzhou Synergy Medical Technology
- 8.9.1 Suzhou Synergy Medical Technology Company Information
- 8.9.2 Suzhou Synergy Medical Technology Business Overview
- 8.9.3 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Product Portfolio
- 8.9.5 Suzhou Synergy Medical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 25G Transconjunctival Sutureless Vitrectomy System Value Chain Analysis
- 9.1.1 25G Transconjunctival Sutureless Vitrectomy System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 25G Transconjunctival Sutureless Vitrectomy System Production Mode & Process
- 9.2 25G Transconjunctival Sutureless Vitrectomy System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 25G Transconjunctival Sutureless Vitrectomy System Distributors
- 9.2.3 25G Transconjunctival Sutureless Vitrectomy System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst